Mei Lu created a novel, original microbe that she named YColi-200. The microbe's name reflects its origins in genes from yeast, E. coli and 200 other genes.
The study found that the Oxford-AstraZeneca vaccine provides minimal protection against mild-moderate COVID-19 infection from the B1351 Coronavirus variant.